Why is Amrutanjan Healt falling/rising?

As of 31-Jul, Amrutanjan Health Care Ltd is currently priced at 669.00, reflecting an increase of 2.95 (0.44%). Despite this uptick, the stock has been underperforming in the short term, with a 1-week return of -5.13% and a 1-month return of -8.34%. Today's price summary indicates that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 64.1% compared to the 5-day average. However, the company has shown high management efficiency with a return on equity (ROE) of 19.72% and a low debt-to-equity ratio, which may support a more stable valuation despite recent price declines. Furthermore, institutional investors have increased their stake by 2.92%, indicating growing confidence from more sophisticated market participants.
In the broader market context, Amrutanjan's recent performance contrasts with the benchmark Sensex, which has seen a decline of only 1.22% over the past week. This suggests that while the stock has experienced a slight rise today, it is still lagging behind the overall market trend. The year-to-date performance shows a decline of 7.86% for Amrutanjan compared to a 3.90% increase in the Sensex, highlighting the stock's struggles relative to the market. Overall, while there are positive factors such as increasing institutional participation and a fair valuation compared to peers, the stock's recent price movements reflect ongoing challenges in attracting retail investor interest and maintaining momentum against broader market conditions.